1134163-24-8

Basic information

• Product Name: rac-5-({p-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl}methyl)-(5-²H)-1,3-thiazolidine-2,4-dione
• Synonyms: rac-5-({p-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl}methyl)-(5-²H)-1,3-thiazolidine-2,4-dione
• CAS NO: 1134163-24-8
• Molecular Weight: 357.437
• Mol File: 1134163-24-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: rac-5-({p-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl}methyl)-(5-²H)-1,3-thiazolidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: rac-5-({p-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl}methyl)-(5-²H)-1,3-thiazolidine-2,4-dione(1134163-24-8)
• EPA Substance Registry System: rac-5-({p-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl}methyl)-(5-²H)-1,3-thiazolidine-2,4-dione(1134163-24-8)

Safety Data

• Hazardous Substances Data: 1134163-24-8(Hazardous Substances Data)

Upstream product

• 112529-15-4 5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}-2,4-thiazolidinedione hydrochloride 
• 105355-27-9 Pioglitazone 

Downstream Products

• 1259828-76-6 (5R)-5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-(5-⁽²⁾H)-1,3-thiazolidine-2,4-dione (-)-O,O'-dibenzoyl-L-tartrate 
• 1259829-13-4 (+/-)-5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-(5-⁽²⁾H)-1,3-thiazolidine-2,4-dione hydrochloride 
• 1259828-75-5 (5R)-5-({p-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl}methyl)-(5-²H)-1,3-thiazolidine-2,4-dione 

Relevant articles and documents

Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone

The invention provides enantiopure deuterium-enriched pioglitazone, pharmaceutical compositions, and methods of treating neurological disorders, cancer, respiratory disorders, metabolic disorders, and other disorders using enantiopure deuterium-enriched p

METHODS OF TREATING BACTERIAL INFECTIONS AND FUNGAL INFECTIONS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE

The invention provides enantiopure deuterium-enriched pioglitazone, pharmaceutical compositions, and methods of treating bacterial infections and fungal infections using enantiopure deuterium-enriched pioglitazone.

5R- 5 -DEUTERATED GLITAZONES FOR RESPIRATORY DISEASE TREATMENT

A composition comprising a 5R-5-deuterated glitazone or a salt thereof, in which composition the 5R-5 deuterated glitazone component includes less than 5% by weight in total of 5R-5-protonated glitazone, 5S-5-protonated glitazone and 5S-5- deuterated glit